All bariatric surgeries are not created equal: insights from mechanistic comparisons
- PMID: 22550271
- PMCID: PMC3410227
- DOI: 10.1210/er.2011-1044
All bariatric surgeries are not created equal: insights from mechanistic comparisons
Abstract
Despite considerable scientific progress on the biological systems that regulate energy balance, we have made precious little headway in providing new treatments to curb the obesity epidemic. Diet and exercise are the most popular treatment options for obesity, but rarely are they sufficient to produce long-term weight loss. Bariatric surgery, on the other hand, results in dramatic, sustained weight loss and for this reason has gained increasing popularity as a treatment modality for obesity. At least some surgical approaches also reduce obesity-related comorbidities including type 2 diabetes and hyperlipidemia. This success puts a premium on understanding how these surgeries exert their effects. This review focuses on the growing human and animal model literature addressing the underlying mechanisms. We compare three common procedures: Roux-en-Y Gastric Bypass (RYGB), vertical sleeve gastrectomy (VSG), and adjustable gastric banding (AGB). Although many would group together VSG and AGB as restrictive procedures of the stomach, VSG is more like RYGB than AGB in its effects on a host of endpoints including intake, food choice, glucose regulation, lipids and gut hormone secretion. Our strong belief is that to advance our understanding of these procedures, it is necessary to group bariatric procedures not on the basis of surgical similarity but rather on how they affect key physiological variables. This will allow for greater mechanistic insight into how bariatric surgery works, making it possible to help patients better choose the best possible procedure and to develop new therapeutic strategies that can help a larger portion of the obese population.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3410227/bin/zef0041228110001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3410227/bin/zef0041228110002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3410227/bin/zef0041228110003.gif)
Similar articles
-
Changes in problematic and disordered eating after gastric bypass, adjustable gastric banding and vertical sleeve gastrectomy: a systematic review of pre-post studies.Obes Rev. 2016 Aug;17(8):770-92. doi: 10.1111/obr.12425. Epub 2016 Jun 14. Obes Rev. 2016. PMID: 27296934 Review.
-
How Far Can Our Expectations Go on Revisional Bariatric Surgery After Failed Adjustable Gastric Banding?Obes Surg. 2021 Apr;31(4):1603-1611. doi: 10.1007/s11695-020-05167-y. Epub 2021 Jan 12. Obes Surg. 2021. PMID: 33438161
-
Patients' expectations and experiences of eating behaviour change after bariatric procedures.Clin Obes. 2018 Oct;8(5):355-365. doi: 10.1111/cob.12273. Epub 2018 Aug 16. Clin Obes. 2018. PMID: 30117282
-
Guiding Patients Toward the Appropriate Surgical Treatment for Obesity: Should Presurgery Psychological Correlates Influence Choice Between Roux-en-Y Gastric Bypass and Vertical Sleeve Gastrectomy?Obes Surg. 2017 Oct;27(10):2759-2767. doi: 10.1007/s11695-017-2876-2. Obes Surg. 2017. PMID: 28815388
-
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Health Technol Assess. 2009. PMID: 19726018 Review.
Cited by
-
Comparison of the Effectiveness of Single Anastomosis Sleeve Ileal Bypass and Roux-en-Y Gastric Bypass in Obese Patients with Type 2 Diabetes.Obes Surg. 2024 Aug 20. doi: 10.1007/s11695-024-07472-2. Online ahead of print. Obes Surg. 2024. PMID: 39162962
-
Liver Oxidative Status, Serum Lipids Levels after Bariatric Surgery and High-Fat, High-Sugar Diet in Animal Model of Induced Obesity.Int J Mol Sci. 2023 Nov 20;24(22):16535. doi: 10.3390/ijms242216535. Int J Mol Sci. 2023. PMID: 38003721 Free PMC article.
-
Bariatric surgery, gastrointestinal hormones, and the microbiome: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars. 2022 Apr 1;2:100015. doi: 10.1016/j.obpill.2022.100015. eCollection 2022 Jun. Obes Pillars. 2022. PMID: 37990718 Free PMC article.
-
Hepatic lipid-associated macrophages mediate the beneficial effects of bariatric surgery against MASH.Res Sq [Preprint]. 2023 Nov 2:rs.3.rs-3446960. doi: 10.21203/rs.3.rs-3446960/v1. Res Sq. 2023. PMID: 37961666 Free PMC article. Preprint.
-
Milkshake Acutely Stimulates Dopamine Release in Ventral and Dorsal Striatum in Healthy-Weight Individuals and Patients with Severe Obesity Undergoing Bariatric Surgery: A Pilot Study.Nutrients. 2023 Jun 8;15(12):2671. doi: 10.3390/nu15122671. Nutrients. 2023. PMID: 37375579 Free PMC article.
References
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. 2010. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241 - PubMed
-
- Chouillard EK, Karaa A, Elkhoury M, Greco VJ. 2011. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study. Surg Obes Relat Dis 7:500–505 - PubMed
-
- Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. 2009. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28:w822–w831 - PubMed
-
- Anderson JW, Konz EC, Frederich RC, Wood CL. 2001. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74:579–584 - PubMed
-
- Weiss EC, Galuska DA, Kettel Khan L, Gillespie C, Serdula MK. 2007. Weight regain in U.S. adults who experienced substantial weight loss, 1999–2002. Am J Prev Med 33:34–40 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials